Скачать или смотреть ARM's 2021 Cell & Gene State of the Industry Briefing

The Alliance for Regenerative Medicine’s annual Cell & Gene State of the Industry Briefing, a top-level gathering for key stakeholders in the field. This webinar includes ARM’s annual yearly update on the sector’s progress, followed by a panel session featuring top CEOs and executives highlighting future inflection points for cell and gene therapies in the coming year.

Introduction & Industry Update
Janet Lambert, CEO, Alliance for Regenerative Medicine

Panel: Looking Ahead – What to Expect for the Cell & Gene Therapy Sector in 2021 and Beyond
Terry-Ann Burrell, Chief Financial Officer, Beam Therapeutics (moderator)
Marianne De Backer, Member of Executive Committee and EVP, Head of Strategy and Business Development & Licensing, Pharmaceuticals Division, Bayer
Sandy Macrae, President & CEO, Sangamo Therapeutics
Ken Mills, CEO, REGENXBIO
Adrian Rawcliffe, CEO, Adaptimmune